BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Aptamer Group Licenses Optimer Binder To Alphazyme For Hot Start PCR Applications

-Exclusive OEM license grants worldwide rights for Optimer® binder in molecular biology applications Royalty structure includes product sales, milesto...

December 31, 2025 | News

Intas Pharmaceuticals Limited Secures Exclusive Needle Free Injection Technology For IVF And Gynecology In India

Intas Pharmaceuticals Limited (“Intas”), a leading multinational pharmaceutical company, has entered into an exclusive agreement with ...

December 30, 2025 | News

EMA CHMP Backs Gotenfia Golimumab Biosimilar Advancing STADA and Bio Thera European Strategy

Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera and to be marke...

December 30, 2025 | News

ABL Bio Lands Strategic 55 Million Funding Boost To Fast Track Next Wave Of Breakthrough Antibody Therapies

Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in equity investment - Accelerating R&D on co...

December 29, 2025 | News

Niowave Extends Actinium 225 Supply Agreement With AstraZeneca To Support Next Generation Cancer Therapies

Niowave will expand its agreement to supply Actinium-225, a highly promising medical isotope, to AstraZeneca 10-year supply agreement ...

December 29, 2025 | News

China Approves First Dual Immunotherapy Neoadjuvant Regimen For MSI H dMMR Colon Cancer

TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment o...

December 26, 2025 | News

Bioeq And Zydus Secure USFDA Approval For Interchangeable Lucentis Biosimilar NUFYMCO

Bioeq AG ("Bioeq"), a Swiss biopharmaceutical company, and Zydus Lifesciences Limited ("Zydus"), an innovation-led life-sciences company with an internatio...

December 24, 2025 | News

GC Biopharma Secures MFDS Approval For Phase 1 Trial Of mRNA Covid 19 Vaccine Candidate

Phase 2 IND submission targeted for the second half of 2026- Demonstrating the competitiveness of GC Biopharma's mRNA platform GC Biopharma (...

December 24, 2025 | News

Merck Secures World First Regulatory Approval For Pimicotinib In Rare Joint Tumour TGCT In China

First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantl...

December 23, 2025 | News

Meiji Seika Pharma Partners With MBC BioLabs To Strengthen Global Biotech Innovation

-Meiji Seika Pharma Co., Ltd. announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting ...

December 22, 2025 | News

Soin Neuroscience And BIOTRONIK Neuro Advance Personalised Spinal Cord Stimulation Research

Soin Neuroscience and BIOTRONIK Neuro announced a research collaboration to advance personalized spinal cord stimulation (SCS) tuning using Soin Neuroscien...

December 22, 2025 | News

Talus Bioscience Enters Strategic Collaboration With PRISM BioLab To Unlock Transcription Driven Drug Targets

Talus Bioscience, Inc. (“Talus Bio”), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRI...

December 19, 2025 | News

Harbour BioMed Enters Global Antibody Collaboration With Bristol Myers Squibb

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunolo...

December 18, 2025 | News

Eccogene Enrols First Patient In Phase 2a MOSAIC Trial For MASH Therapies

Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammato...

December 18, 2025 | News

Stay Connected